STATIN-FIBRATE REPORT: Focus on Safety
The report suggests that there is no mortality benefit in these patients. This is an important observation since 3 out of 4 patients on statins are potentially in this category, these drugs have known side effects and this drug class accounts for $26 billion annual income for the pharmaceutical industry. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.